Acta Scientific Gastrointestinal Disorders (ISSN: 2582-1091)

Research Article Volume 3 Issue 9

Recurrence of Helicobacter pylori Infection after Successful Eradication Therapy in Egyptian Patients

Mohamed AA Bassiony*, Amr T El Hawary and Marwan N Elgohary

Gastroenterology and Hepatology Unit, Internal Medicine Department, Zagazig Faculty of Medicine, Egypt

*Corresponding Author: Mohamed AA Bassiony, Gastroenterology and Hepatology Unit, Internal Medicine Department, Zagazig Faculty of Medicine, Egypt.

Received: June 16, 2020; Published: August 24, 2020

×

Abstract

Background: Helicobacter pylori (H. pylori), a highly prevalent gastrointestinal organism, infects more than 50% of the global population. It is the most common risk factor for peptic ulcer disease, cancer stomach and gastric lymphoma.

Eradication therapy regimens for H. pylori are highly effective. However, bacterial resistance to antibiotics and patients non-adherence to the treatment regimens significantly increased the recurrence rates of H. pylori infection in the last few decades.

Study Aim: To assess the prevalence and possible risk factors of H. pylori recurrence in Egyptian patients after eradication therapy.

Patients and Methods: We evaluated and followed up 157 patients for one year after confirmed successful eradication of H. pylori infection. We investigated the patients at 3, 6, 9 and 12 months for recurrence of H. pylori infection using urea breath and stool antigen tests.

Results and Conclusion: We found a one-year recurrence rate of 19% after successful eradication therapy of H. pylori. The education level of the patients and alcohol consumption were the most significant predictors of H. pylori recurrence. The one-year recurrence rate in our study is high but comparable to those reported in the developing countries most probably due to high rates of re-infection and non-adherence to the preventive measures.

Keywords: H. pylori; Proton Pump Inhibitors; Eradication Therapy; Bacteria Resistance; Recurrence

×

References

  1. Morgan R., et al. “Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities”. Journal of the American Medical Association6 (2013): 578-586.
  2. Giannakis M., et al. “Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells”. Proceedings of the National Academy of Sciences of the United States of America 11 (2008): 4358-4363.
  3. Sugano K., et al. “Kyoto global consensus report on Helicobacter pylori gastritis”. Gut9 (2015): 1353-1367.
  4. Jagadish C and Paul N. “Epidemiology and pathophysiology of Helicobacter pylori infection in children”. Indian Journal of Pediatrics 3 (2007): 287-290.
  5. Holly M., et al. “Helicobacter pylori Persistence: an Overview of Interactions between pylori and Host Immune Defenses”. Clinical Microbiology Reviews 19.4 (2006): 597-613.
  6. Lender N., et al. “Review article: associations between Helicobacter pylori and obesity - an ecological study”. Alimentary Pharmacology and Therapeutics 1 (2014): 24-31.
  7. Jackson L., et al. “A population-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation”. Helicobacter5 (2009): 108-113.
  8. Soto G., et al. “Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy”. Journal of Infectious Diseases 9 (2003): 1263-1275.
  9. Bardhan K. “Epidemiological features of Helicobacter pylori infection in developing countries”. Clinical Infectious Diseases 5 (1997): 973-978.
  10. Thong-Ngam D., et al. “Incidence of Helicobacter pylori Recurrent Infection and Associated Factors in Thailand”. Journal of the Medical Association of Thailand 7 (2007): 1406-1410.
  11. Fernandesi Y., et al. “Recurrence rate of pylori five years or more after successful eradication”. Arquivos de Gastroenterologia 53.3 (2016): 152-155.
  12. Chey W., et al. “ACG Clinical Guideline: Treatment of Helicobacter pylori Infection”. American Journal of Gastroenterology 2 (2017): 212-239.
  13. Hooi J., et al. “Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis”. Gastroenterology2 (2017): 420-429.
  14. Hildebrand P., et al. “Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults”. Gastroenterology 4 (2001): 792-798.
  15. Okimoto T., et al. “Is the recurrence of Helicobacter pylori infection after eradication therapy resultant from recrudescence or reinfection in Japan?” Helicobacter 3 (2003): 186-191.
  16. Benajah DA., et al. “Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco)”. Clinics and Research in Hepatology and Gastroenterology 5 (2013): 519-526.
  17. Cheon J., et al. “Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea”. European Journal of Gastroenterology and Hepatology 5 (2006): 515-519.
  18. Zhang L., et al. “Relationship between Alcohol Consumption and Active Helicobacter pylori Infection”. Alcohol and Alcoholism 1 (2010): 89-94.
  19. Tsai C., et al. “First-line Helicobacter pylori eradication among patients with chronic liver diseases in Taiwan”. The Kaohsiung Journal of Medical Sciences8 (2016): 397-402.
  20. Barik S. “Helicobacter pylori Infection in Developing Countries: The Burden for How Long?” Saudi Journal of Gastroenterology 3 (2009): 201-207.
×

Citation

Citation: Mohamed AA Bassiony. “Recurrence of Helicobacter pylori Infection after Successful Eradication Therapy in Egyptian Patients”.Acta Scientific Gastrointestinal Disorders 3.9 (2020): 09-13.




Metrics

Acceptance rate35%
Acceptance to publication20-30 days
Impact Factor0.622

Indexed In




News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 25, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US